Estimated prevalence of diabetes among adolescents higher than previously reported

July 19, 2016

In a study appearing in the July 19 issue of JAMA, Andy Menke, Ph.D., of Social & Scientific Systems, Silver Spring, Md., and colleagues estimated the prevalence of diabetes among U.S. adolescents, the percentage of those who were unaware of their diabetes, and the prevalence of prediabetes using nationally representative data.

The researchers used 2005-2014 National Health and Nutrition Examination Survey (NHANES) data (in which all relevant glucose data were available) from adolescents age 12 to 19 years who were randomly selected for a morning examination session after fasting.

Of 2,606 adolescents included, 62 had diabetes, 20 were undiagnosed, and 512 had prediabetes. The weighted prevalence of diabetes was 0.8 percent, of which 29 percent was undiagnosed, and the prevalence of prediabetes was 18 percent. Prediabetes was more common in males (22 percent) than females (13 percent). Compared with non-Hispanic white participants, the percentage of adolescents with diabetes who were undiagnosed (4.6 percent) and the prediabetes prevalence (15 percent) were higher in non-Hispanic black participants (50 percent and 21 percent, respectively) and Hispanic participants (40 percent and 23 percent, respectively). Diabetes and prediabetes prevalences did not change over time.

"To our knowledge, these are the first estimates of diabetes in a nationally representative sample of U.S. adolescents using all 3 American Diabetes Association recommended biomarkers. The estimates are higher than previously reported; 1 study found diagnosed diabetes in 0.34 percent of participants aged 10 to 19 years. A relatively large proportion was unaware of the condition, particularly among non-Hispanic black participants and Hispanic participants, indicating a need for improved diabetes screening among adolescents. These findings may have important public health implications because diabetes in youth is associated with early onset of risk factors and complications," the authors write.
-end-
(doi:10.1001/jama.2016.8544; the study is available pre-embargo at the For the Media website)

Editor's Note: This work was supported by a contract from the National Institute of Diabetes and Digestive and Kidney Diseases. All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest and none were reported.

Media Advisory: To contact Andy Menke, Ph.D., email Mona Feldman at MFeldman@s-3.com.

To place an electronic embedded link to this study in your story This link will be live at the embargo time: http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2016.8544

The JAMA Network Journals

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.